Eisai Partners Arena Pharma To Commercialise Lorcaserin In US
Lorcaserin is used for the treatment of obesity, including weight loss, for patients who are obese (Body Mass Index or BMI = 30) or overweight (BMI = 27)
WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration, aiming to widen patient access to advanced care, clinical expertise, and research initiatives throughout central Pennsylvania, US.
Convivia is designed to reduce systemic acetaldehyde exposure and related symptoms in liver enzyme aldehyde dehydrogenase (ALDH2) deficiency, or ethanol intolerance, following alcohol consumption. As per the terms